| Literature DB >> 36035748 |
Jøran Hjelmesæth1,2, Agneta Sjöberg3.
Abstract
Background: The aim of this article (scoping review) is to elucidate the current knowledge for the potential role of body weight for setting and updating Dietary Reference Values (DRVs) and Food-Based Dietary Guidelines (FBDGs). The following research questions were formulated:What is known about the association between intakes of specific nutrient and/or foods (exposure/intervention) and body weight (outcome) in the general population?What is known about the association between body weight (exposure) and intakes of specific nutrient and/or foods (outcomes)?Is there any evidence suggesting specific effects of foods or nutrients on body weight independent of caloric content?Entities:
Keywords: Adults; Body weight; Children; Diet; Foods; Human; Macronutrients; Obesity; Overweight; Scoping review
Year: 2022 PMID: 36035748 PMCID: PMC9396931 DOI: 10.29219/fnr.v66.8814
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.221
Fig. 1Flow diagram.
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71
Results according to intervention/exposure category
| First author, year publication | Ref. | Study design, number included in analysis | Country | Aim | Population | Intervention, exposure, and outcomes | Key findings |
|---|---|---|---|---|---|---|---|
| A) Sugar intake or SSBs (SSB, | |||||||
| Bes-Rastrollo M, 2016 | ( | Narrative review of systematic reviews (SR) and meta-analyses (MAs) ( | Spain | ‘To summarize the evidence from the SRs and MAs we conducted a comprehensive literature review to include those SRs based on the topic of SSBs as a potential risk factor for weight gain or obesity’. | Human studies | SSB consumption and weight gain or obesity | ‘Added sugars, especially SSB consumption, are an important risk factor for weight gain and obesity’. |
| Kahn R, 2014 | ( | Point narrative review | USA | To discuss whether ‘any dietary or added sugar has a unique or detrimental impact relative to any other source of calories on the development of obesity or diabetes’. | Not addressed | Sugar and obesity/diabetes | ‘If there are any adverse effects of sugar, they are due entirely to the calories it provides, and it is therefore indistinguishable from any other caloric food. Excess total energy consumption seems far more likely to be the cause of obesity and diabetes’. |
| Bray GA, 2014 | ( | Point narrative review | USA | ‘We provide our opinion and review of the data to date that we need to reconsider consumption of dietary sugar based on the growing concern of obesity and type 2 diabetes’. | Not addressed | Sugar and obesity/diabetes | ‘Consumption of calorie-sweetened beverages has continued to increase and plays a role in the epidemic of obesity, the metabolic syndrome, and fatty liver disease. Reducing intake of soft drinks is associated with less weight gain’. |
| Massougbodji J, 2014 | ( | SR of reviews ( | USA | Objectives: ‘1) identify published reviews on the relation between SSBs and body weight, 2) assess the scientific quality of these reviews by using two different scoring systems, 3) position the authors’ conclusions on a Likert scale ranging from 0 = no evidence of a causal relation to 5 = strong evidence of a causal relation, and 4) identify study characteristics associated with the authors’ position, including the quality scores and source of funding’. | Adults, children, and adolescents | SSBs and body weight | ‘In conclusion, many reviews that have examined the association between SSB consumption and obesity/weight gain were recently published, but there is no consensus on the strength of the evidence on causality. As measured by two quality-assessment tools, the methodologic quality of the reviews did not explain the orientation of the authors’ conclusions’. ‘We found that reviews funded by the industry were less likely to conclude that there was a strong association between SSB consumption and obesity/weight gain’. |
| Ebbeling CB, 2014 | ( | Narrative review | USA | ‘The purpose of this review is not to underscore the debate but rather to consider how recently published data pertaining to SSBs contribute to the evidence base for preventing and treating obesity, with application to caring for patients’. | Adults and children | SSBs and body weight/obesity | ‘Available data provide an evidence base for counselling patients to reduce consumption of SSBs’. |
| Sievenpiper JL, 2012 | ( | SR of intervent studies and MA ( | Canada | ‘To review the effects of fructose on body weight in controlled feeding trials’. | Adults | Fructose and body weight | ‘Our aggregate analyses of the effects of fructose in 31 trials with isocaloric comparisons (637 participants) and 10 trials with hypercaloric comparisons (119 participants) showed divergent results. The isocaloric trials did not provide consistent evidence for a body weight–increasing effect of fructose, whereas the hypercaloric trials did’. |
| Te Morenga L, 2012 | ( | SR and MA of RCTs ( | New Zealand | ‘To summarise evidence on the association between intake of dietary sugars and body weight in adults and children’. | Adults and children | Dietary sugars and body weight | Reduced intake of dietary sugars showed a decrease in body weight (0.80 kg, 95% CI 0.39 to 1.21); increased intake of sugars showed a weight increase (0.75 kg, 0.30 to 1.19). Isoenergetic replacement of dietary sugars with other carbohydrates resulted in no change in body weight (0.04 kg, −0.04 to 0.13). |
| Mattes RD, 2011 | ( | SR and MA ( | USA | To critically review data from RCTs and evidence-based reviews through January 2009 concerning effects of consumption of nutritively sweetened beverages (NSBs) on changes in body weight and adiposity. | Children, adolescents, and adults | Nutritively sweetened beverages and body weight | ‘Meta-analysis of studies providing access to results separately for subjects overweight at baseline showed a significant effect of a roughly 0.35 standard deviations lesser BMI change (i.e. more weight loss or less weight gain) relative to controls. The current evidence does not demonstrate conclusively that NSB consumption has uniquely contributed to obesity or that reducing NSB consumption will reduce BMI levels in general’. |
| Laviada-Molina, 2020 | ( | SR and MA of RCTs, | Mexico/UK | ‘To assess the effects of nonnutritive sweeteners (NNS) on body weight’ | General population, both subjects with healthy weight and subjects with overweight/obesity of all ages, no conditions or comorbidities | NNS vs sucrose/placebo/water/nothing. Primary outcome: difference in body weight between NNS and comparators. NNS, also known as non-caloric/very low-calorie sweeteners or artificial sweeteners such as aspartame, saccharin, sucralose, stevia, cyclamate, and acesulfame-K. | ‘Participants consuming NNS showed significant weight/BMI differences favouring NNS compared with nonusers (1.3 kg)’. ‘NNS versus placebo/no intervention and NNS versus water produced no effect’. ‘When comparing NNS versus sucrose, significant weight/BMI differences appeared favouring NNS’. |
| Cavagnari BM, 2019 | ( | Special article-narrative review of studies with several study designs | Argentina | ‘Main objective of this article is to review the available evidence on the consumption of non-caloric sweeteners in relation to body weight’. | Children and adults | Non-caloric sweeteners and body weight | ‘Currently, the higher quality of evidence (RCTs, SRs and meta-analyzes of RCTs) shows that consumption of NCS -in replacement of sugars- could be useful for reducing calorie intake and relative body weight in adults’. |
| Mosdøl A, 2018 | ( | Scoping review of reviews ( | Norway | ‘To determine the extent and type of summarized evidence published the last 10 years regarding the potential effects of intense sweeteners on appetite and weight change’. | Children and adults | Intense sweeteners | ‘Apart from the observational studies, the presented primary evidence in humans is dominated by small studies with short follow-up considered insufficient to assess weight change’. ‘With few exceptions, the reviews on intense sweeteners and weight change underuse systematic methodology, and thus, the available evidence’. |
| Rogers PJ, 2016 | ( | SR and MA of RCTs and prospective cohort studies ( | UK | ‘To bring together the totality of evidence to test the primary (null) hypotheses that low-energy sweeteners (LES) consumption per se or as a replacement for caloric sweeteners in foods or beverages has no effect on EI or BW outcomes in adults or children’. | Children and adults and animals | Low-energy sweeteners (LES) versus sugar or water and energy intake and body weight | ‘We found a considerable weight of evidence in favour of consumption of LES in place of sugar as helpful in reducing relative EI and BW, with no evidence from the many acute and sustained intervention studies in humans that LES increase EI. |
| Miller PE, 2014 | ( | SR and MA of RCTs ( | USA | ‘To systematically review and quantitatively evaluate results from RCTs and prospective cohort studies, separately, that examined the relation between low-calorie sweeteners and body weight, fat mass, BMI, and waist circumference’. | Adults and children | Low-calorie sweeteners and body weight | Substituting Low-calorie sweeteners (LCS) for sugar modestly reduced body weight (0.80 kg), BMI, fat mass, and waist circumference. Among prospective cohort studies, LCS intake was not associated with body weight or fat mass, but was significantly associated with slightly higher BMI (0.03; 95% CI: 0.01, 0.06). |
| B) Whole grain (WG, | |||||||
| Maki KC, 2019 | ( | Review and MA of RCTs ( | USA | ‘To provide an updated quantitative analysis of data from both observational studies and RCTs examining the relationship of whole grain (WG) intake with body weight’ | Adults | Primary outcome RCT data meta-analysis change in body weight (kg), diff. between the exposed group with the highest WG intake reported and the control group. WG intake 32 g/d to 215 g/d for the WG interventions and 0–19 g/d for the studies reporting WG daily intake for controls. | ‘Higher WG intake is significantly inversely associated with BMI in observational studies but not in RCTs up to 16 weeks in length’. Meta-regression analysis of cross-sectional evidence showed a significant inverse relationship between the WG intake and BMI. ‘Prospective cohort studies support this relationship, with baseline WG intake and change in WG intake generally showing inverse associations with weight change during follow-up periods of four to 20 years, particularly in the studies with larger numbers of subjects’. |
| Pol K, 2013 | ( | MA of RCTs ( | Denmark | ‘To evaluate the evidence from randomized controlled studies for a role of whole grain in terms of body weight and body composition compared with a non-whole-grain or refined-grain control in apparently healthy adults’. | Adults | Whole grain in terms of body weight and body composition compared with a non-whole-grain or refined-grain control | ‘The current meta-analysis does not lend credence to a role for whole grain in body weight management. However, we did show that whole grain beneficially affected the percentage of body fat (–0.5%). Studies were of 2–16-week duration, and most studies lasted only 4–6 weeks’. ‘The relatively short duration of intervention studies (16 week or less) may explain the lack of difference in body weight and fat’. |
| Karl JP, 2012 | ( | Narrative review | USA | To ‘examine the evidence for a role of whole grain (WG) in body weight regulation’. | Adults (mainly) and children | WG and body weight regulation | ‘In summary, intervention trials conducted to date have failed to demonstrate beneficial effects of WG intake on body weight regulation despite observational studies consistently demonstrating that high intakes of WG are associated with lower BMI, and the existence of a variety of mechanisms that could result in WG-mediated effects on body weight’. |
| Bautista-Castaño I, 2012 | ( | SR: cross-sectional ( | Spain | ‘To analyze the epidemiological evidence regarding the influence of dietary patterns that include refined and whole-grain bread consumption on an individual’s ponderal status’. | Adults and children | Effect of whole-grain versus refined bread consumption on body weight measures | ‘The greater proportion of studies in this review indicated that the groups of food items, dietary patterns, or dietary models that included bread did not adversely affect ponderal status, and that those that included wholegrain bread even provided benefit. In addition, the dietary patterns that included refined bread achieved poorer results than those that contained whole-grain bread, and were associated with a more favorable distribution of abdominal body fat. Of the five studies that related food patterns that included bread to the distribution of abdominal fat, four were associated with refined bread’. |
| Giacco R, 2011 | ( | Viewpoint/narrative review | Italy | ‘To 1) review the available scientific literature on the relation-ship between whole grain consumption and body weight regulation; 2) evaluate the potential mechanisms by which whole grain intake may help reduce overweight and 3) try to understand why results of cross-sectional and prospective epidemiological studies and of clinical trials have produced diverging evidence on this topic’. | Adults (mainly) and adolescents | The relationship between whole grain consumption and body weight regulation | ‘All the studies reviewed in this manuscript demonstrate that a higher intake of whole grains is associated with lower BMI in epidemiological studies. However, so far, the results from a few intervention trials investigating whether a whole grain-low calorie diet is able to reduce body weight, have failed to demonstrate a cause/effect relation’. |
| Jovanovski E, 2020 | ( | SR and MA of RCTs, | Canada | ‘To summarize and quantify the effects of addition of viscous fiber to the diet [agar, alginate, β-glucan, guar gum, konjac, viscous fiber blend (VFB) (konjac, alginate, and xanthan), psyllium, or xanthan gum] compared with an appropriate control (i.e. fiber-free supplement, nonviscous fiber, placebo, background diet) on ≥1 anthropometric measure’ | Overweight or normal weight people with/without diabetes or increased (CVD) risk, median (range) age 51 (16–70), BMI 27 (19–33) | Effect of viscous fiber supplemented to an ad libitum diet along with comparator diets. Both whole food sources (i.e. oats and barley) and isolated fibers were included. Median dose of 8 g viscous fiber/d (range: 0.8–36 g/d) | ‘Pooled analysis of 62 trials ( |
| Wanders AJ, 2011 | ( | SR of RCTs (for body weight, 59 papers with 66 comparisons) | The Netherlands | ‘To summarize the available literature on the relationship between specific dietary fibre types and three outcome variables: subjective appetite, energy intake and body weight’. | Adults | Effects of dietary fiber types and three outcome variables: subjective appetite, energy intake, and body weight. | ‘Out of 66 fibre–control comparisons, 39 showed an absolute reduction in body weight (59%). Irrespective of the fibre group, fibre reduced body weight with 1.3% over the complete study period (on average 0.72 kg), which corresponds to a reduction of 0.4% per 4 weeks. All comparisons on dextrins (100%) and marine polysaccharides (100%) reduced body weight. Other fibres with a high effect rate on weight loss were chitosan (86%), fructans (67%) and arabinoxylans |
| Rahmani J, 2019 | ( | SR and MA of RCTs ( | Iran | ‘To summarize the effect of cereal beta-glucan consumption on body weight, BMI, waist circumference and a total energy intake’. | Adults | Effects of cereal beta-glucan on energy intake, body weight, BMI, or waist circumference. Mean intervention duration of studies: 7.40 ± 7.25 weeks. Dose of betaglucan varied between 0.88 and 9.9 mg/d. | ‘Ingestion of beta-glucan containing products improves weight loss and reduces BMI in the intervention group compared to controls’. |
| C) Vegetables, fruits, nuts, and seeds ( | |||||||
| Mytton OT, 2014 | ( | SR and MA of RCTs ( | UK | ‘To quantify the relationship between changes in vegetable and fruit intake, energy intake and body weight’. | Adults and children | Increase vegetable/fruit consumption, 4–52 weeks, mean 15 weeks. | Mean difference between arms 133 g ‘trials of increased vegetable or fruit consumption, in the absence of guidance to reduce consumption of other foods, result in either a small reduction in body weight or reduced weight gain relative to controls.(mean difference 0.68 kg, 0.15–1.20). No dose response effect’. |
| Gheflati A, 2019 | ( | SR and MA of RCTs ( | Iran | ‘To evaluate the clinical effects of pomegranate consumption on weight and body composition’. | Adults | Pomegranate extract, pomegranate juice, pomegranate vinegar versus placebo capsule, control beverage, water, nothing | ‘Participants who consumed pomegranate and its products had no significant reduction in body weight, BMI, WC and body fat percent’. |
| Onakpoya I, 2017 | ( | SR and MA of RCTs ( | UK | ‘To evaluate the evidence for or against the effectiveness of grapefruits (Citrus paradisi) on body weight, blood pressure, lipids’. | Adults with obesity | 6–12 weeks fresh grapefruit, frozen juice, and capsules | ‘Grapefruit supplementation does not lead to statistically significant reductions in body weight in obese Adults’. |
| Perna S, 2016 | ( | SR and MA of non-RCTs and RCTs ( | Italy | To review the effects of hazelnut consumption on blood lipid levels as well as on body weight. | Adults | 28–84 days with a dosage of hazelnuts ranging from 29 to 69 g/d | ‘Out of eight studies with BMI data, six showed absence of difference, and one showed a significant decrease ( |
| Tan SY, 2014 | ( | Narrative review with a number of RCTs assessed | USA | Focuses on the role of nut consumption on appetite, energy intake, energy metabolism, and body weight. | Adults | Nuts and body weight | ‘Epidemiologic studies indicate that incorporating nuts into diets on a regular basis does not compromise, and may aid, weight maintenance’. ‘Nut consumption does not promote weight gain’. |
| Jackson CL, 2014 | ( | Narrative review | USA | ‘To determine and reach consensus with regard to nuts’ association with long-term weight change and obesity risk’. | Adults | Nuts and BW change and obesity | ‘Based on the available evidence from prospective studies (also supported by RCTs and cross-sectional studies), long-term nut consumption is associated with lower weight gain overweight/obesity’. |
| Vadivel V, 2012 | ( | Narrative review | Germany | ‘To elucidate the link between nut consumption and body weight gain’. | Adults | Nut consumption and body weight gain | ‘Several epidemiologic research studies and short-term feeding trials have shown that moderate nut consumption does not increase body weight’. |
| Kim SJ, 2016 | ( | SR and MA of RCTs (19 reports, 21 trials). Median 6-week follow-up | Canada | To assess studies examining the effects of dietary pulse intake compared with the effects of a comparator diet on body weight. | Adults | Effect of dietary versus isocaloric comparator diets on body weight, WC and BF% | Pooled analysis showed a small weight reduction of 0.34 kg in diets that contained dietary pulses (from 80 to 278 g/d; median intake: 132 g/d or w1 serving/d) compared with diets without a dietary pulse intervention over a median duration of 6 weeks ( |
| Darooghegi Mofrad M, 2019 | ( | SR and MA of RCTs ( | Iran | ‘To evaluate the effectiveness of psyllium supplementation on weight loss in adults’. | Adults | Psyllium consumption (whether prescribed through supplements or added to foods) and body weight measures | ‘This study did not show a significant effect of psyllium on body weight, body mass index, and waist circumference in comparison with control group in adults’ |
| Mohammadi-Sartang M, 2017 | ( | SR and MA of RCTs ( | Iran | ‘To help quantify the overall effects of flaxseed products on body composition indices in adults’. | Adults | Flaxseed supplementation whole flaxseed 13–90 g/d, flaxseed oil 1–15.4 g of ALA per day and lignin 50–600 mg/d. | ‘Pooled results from the random-effects model showed that BMI was reduced in the flaxseed group compared with the control group (WMD: –0.30 kg/m2, 95% CI: –0.53,–0.08, BW 0.99 kg). However, body composition indices were reduced with whole flaxseed consumption only, in trials lasting ≥12 weeks, and if BMI≥ 27’. |
| Raeisi-Dehkordi H, 2019 | ( | SR ( | Iran | ‘To perform a SR of RCTs that examined the effect of Canola Oil consumption on BW and other anthropometric indexes compared with other sources of dietary fats’. | Adults | Effect of oral ingestion of pure or conventional CO (rapsolje) on BW, both supplements and food? | ‘CO intake significantly decreases BW (–0.30 kg); however, CO intake did not significantly affect BMI’. |
| D) Dairy/dairy proteins ( | |||||||
| Geng T, 2018 | ( | SR and MA of RCTs ( | Singapore/China/USA | ‘To systematically examine the effect of dairy consumption on body weight and body composition. We also sought to compare the effects of trials with and without energy restriction on body composition’. | Adults ( | Dairy consumption and body weight/composition (1–36 months) | This meta-analysis of 37 RCTs with 3,007 adults showed that there was no significant difference in body weight change between the dairy intervention and control groups overall (0.01 kg, 95% CI: −0.25, 0.26). High dairy consumption was associated with decreased body fat (−0.23 kg, 95% CI: −0.48, 0.02) and WC (−1.37 cm, 95% CI: −2.28, −0.46), whereas an increase in lean mass (0.37 kg, 95% CI: 0.11, 0.62). A significant increase in body weight was seen during dairy intervention in 19 RCTs without energy restriction (0.36 kg, 95% CI: 0.01, 0.70 kg, |
| Dewansingh P, 2018 | ( | SR and MA of RCTs ( | The Netherlands | To assess the effectiveness of dairy or dairy components on the nutritional status and physical fitness. | Adults 55 years or older | Supplementation with dairy components | ‘These systematic review and meta-analysis showed that the dairy components protein and vitamin D have beneficial effects for older adults’. Protein supplementation increased BW by 1.13 kg. |
| Stonehouse W, 2016 | ( | SR and MA of RCTs ( | Australia | To investigate the effects of dairy food/supplements during energy restriction on body weight and composition in 18–50-year-old. | Adults 18–50 years | Calorie restriction (most > 500 kcal/d), dairy foods ( | ‘Overall (when dairy food and supplement studies were pooled), increased dairy intake combined with energy restriction resulted in a significantly greater reduction in body weight (Figure 2) and body fat mass (Figure 3) compared to control interventions (body weight: –0.92 kg [–1.63, –0.20 kg], smaller loss of lean mass (0.36 kg, 0.01–0.71)’ |
| Booth AO, 2015 | ( | SR and MA of RCTs ( | Australia | ‘This review comprehensively and systematically analyses the available evidence assessing the effects of dairy and added Ca supplementation on body weight’. | Adults | Dairy, added calcium, and body weight | ‘In summary, a robust meta-analysis method with large subject numbers showed that there was no evidence that increased Ca provision in the form of supplements or dairy foods reduces body weight or body fat. There was some evidence that consumption of approximately 3 servings/d of reduced fat dairy foods (approximately 1300 mg/d Ca) in the presence of energy restriction resulted in a small, but significant greater loss of body fat mass over a short period of 4 months. This indicates that low fat dairy foods can be included as part of a healthy weight loss diet without having negative effect on body weight or body composition in the short term’. |
| Chen M, 2012 | ( | MA of RCTs ( | USA | ‘To evaluate whether increasing the consumption of dairy products could promote weight loss’. | Adults | Effect dairy consumption on body weight and body fat in adults | ‘This meta-analysis does not support the beneficial effect of increasing dairy consumption on body weight and fat loss in long-term studies (≥1 year) or studies without energy restriction’. ‘There was no significant difference in body weight changes between the dairy intervention and control groups (–0.14 kg; 95% CI: –0.66, 0.38 kg; Figure 2A); however, a significant reduction that favored dairy products in body fat was shown (–0.45 kg; 95% CI: –0.79, –0.11 kg; Figure 2B)’. |
| Abargouei AS, 2012 | ( | SR and MA ( | Iran | To summarize the evidence on the effect of dairy consumption on body weight and composition and to identify possible sources of heterogeneity between studies. | Adults, 18–85 years | Effect of dairy consumption on body weight and composition | ‘In conclusion, our systematic review and meta-analysis on RCTs indicated that increasing dairy consumption without energy restriction might not lead to a significant change in weight and body composition, whereas inclusion of dairy products in weight loss energy-restricted diets would result in a greater reduction of weight, fat mass and WC and gain in lean body mass compared with the conventional weight loss diets’. |
| Bendtsen LQ, 2013 | ( | Review | Denmark | ‘To examine the existing evidence from controlled clinical trials investigating the effects of consumption of dairy protein (total dairy protein, whey, and/or casein) and other protein sources on …., body weight, and body composition’. | Not addressed | Effect of dairy consumption on body weight and composition and more | Despite good evidence to support that protein is beneficial in increasing and maintaining weight loss due to effects on appetite regulation and energy expenditure, data are inconclusive with regard to the effects of various protein types. |
| Dougkas A, 2011 | ( | SR and MA of studies with various study designs (cross-sectional, prospective observational), | UK | ‘The present review specifically examines the evidence from epidemiological studies and intervention trials that have investigated the relationship between dairy product consumption and dietary Ca, and measures of adiposity’. | Adults | Dairy product consumption and dietary Ca, and measures of adiposity. | ‘Although inconsistencies between studies certainly exist, the overall assessment of the epidemiological evidence is suggestive of a modest negative association between dairy consumption and body weight. The overall linear regression analysis, based on the 18 trials that examined dietary Ca (with the majority of dietary Ca derived from dairy products), indicates that an increase in Ca intake from 400 to 1,200 mg/d would be associated with a decrease in BMI from 25.6 to 24.7 kg/m2. Evidence derived from intervention studies without energy restriction does not predict any effect of dairy products on either weight loss or weight gain. During energy restriction, although the results are still inconsistent, there are indications of a possible beneficial effect of dairy products in weight loss treatments whilst maintaining lean tissue in an overweight population’. |
| Anderson GH, 2011 | ( | Narrative review (Nestle) | Canada | ‘Review of the role of dairy in the regulation of body weight and the role of cow’s milk proteins in the regulation of satiety, food intake, blood glucose and their mechanisms of action’. | Adults | Dairy and body weight | ‘Several epidemiological studies of adults have reported an inverse in association between frequent dairy intake and adiposity as measured by the body mass index’. |
| E) Diets according to food or macronutrient composition (low GI-diets, vegan/vegetarian, low-carb, and low-fat) ( | |||||||
| Vega-López, S, 2018 | ( | Review of RCTs and observational studies comparing foods, meals, or diets with distinct GI ( | USA | ‘To summarize the most recent evidence for short-term and long-term (e.g. weight) health effects associated with different types of GI diets’. | Adults | Different GI diets | ‘Findings regarding an association between GI or GL and body weight are equivocal (observational studies). Although one shorter-term study (8-week) suggested a benefit from lowering the GI of the diet for greater weight loss, highly-controlled feeding interventions (3–18 months) suggested that manipulating the GI does not make a difference in weight-related outcomes (Table 4)’. |
| Chiavaroli L, 2018 | ( | SR and MA of RCTs ( | Canada | ‘To quantify the effect of pasta alone or in the context of low-GI dietary patterns on body weight and measures of adiposity relevant to the prevention and management of overweight and obesity’. | Adults | Pasta alone (none) or in the context of low-GI dietary patterns | Pasta in the context of low-GI dietary patterns reduced body weight by −0.63 kg (−0.84 to –0.42 kg; |
| Munsters MJ, 2014 | ( | Narrative review | Netherlands | 1. Discuss the concepts of body weight regulation, substrate partitioning,2. Address dietary strategies to …. and to achieve and maintain a healthy body weight. | General population | Dietary strategies that may improve metabolic profile and BW in obesity, and to achieve and maintain a healthy body weight. | ‘A growing body of evidence suggests that dietary strategies with the aim to reduce postprandial insulin response and increase fat oxidation, and that tend to restore metabolic flexibility, have a place in the prevention and treatment of obesity and associated metabolic disorders’. |
| Barnard ND, 2015 | ( | SR and MA of clinical trials ( | USA | ‘To identify the body of data from clinical trials using vegetarian (including vegan) diets as interventions and to quantify the weight loss resulting from the prescription of these diets in adults, independent of the confounding effects of exercise or caloric limits’. | Adults | Vegan/vegetarian diets of 3–13 months duration without energy intake limitations versus untreated controls (2 low-fat vegan, 1 raw vegan, 1 vegan/lacto-vegetarian) | ‘Our meta-analysis showed that the prescription of vegetarian or vegan diets was associated with a mean weight reduction of 3.4 (2.4–4.4) kg in an intention-to-treat analysis and 4.6 (3.8–5.4) kg in a completer analysis’. |
| Kirkpatrick CF, 2020 | ( | Review of MAs of RCTs, | USA | ‘Review evidence on the effects of CHO-restricted dietary patterns compared to dietary patterns with higher CHO content on body weight and glycemic control’. | Adults with overweight/obesity with/without diabetes/prediabetes | CHO-restriction versus HCLF very-low-CHO <25–50 g CHO/d; low CHO 50–130 g CHO/d) | ‘CHO-restricted interventions may result in greater weight loss and glycemic control in the short term (≤6 months) compared to HCLF interventions. However, in the long term (especially those > 12 months), evidence does not support the view that CHO-restricted dietary patterns are superior to HCLF dietary patterns for weight loss or T2D management’. |
| Kirkpatrick CF, 2019 | ( | Review of MA of RCTs and non-RCTs, | USA | Review the characteristics of low- and very-low-CHO diets and their impacts on metabolic pathways and on weight loss. | Adults with overweight/obesity | Low-CHO/high-fat versus high-CHO and/or low fat (mean CHO intake in the low- and very-low-CHO diet groups at the end of follow-up exceeded 50 g/d in all except one study) | ‘Short-term (≤6 months) hypocaloric low-CHO and very low-CHO diets may result in greater weight loss than hypocaloric high-CHO, low-fat (HCLF) diets. |
| Mansoor N, 2015 | ( | MA of RCTs ( | Norway | ‘To compare a typical LC diet defined as a CHO intake of 20–30 g/d in the first phase or <20% of total energy with traditional LF diets composed of <30% of energy as fat and limited energy content, as well as determine the effects on long-term weight loss and several CVD risk factors in healthy adults’. | Adults | Low-Carb versus Low_Fat, duration 6–24 months | ‘Compared with subjects on LF diets, subjects on LC diets experienced significantly greater weight loss after 6 months to 2 years of intervention’ (WMD –2 17 kg; 95% CI –3·36, –0·99)’ |
| Martens EA, 2014 | ( | Narrative review | Netherlands | ‘To specify how protein diets can be applied as a clinical approach for body weight loss and weight maintenance’. | Not addressed | Protein diets and body weight | ‘In adults, a protein intake of 0.8–1.2 g/kg/d is sufficient to sustain satiety, energy expenditure, and FFM, independent of a dietary ‘low-carb’ content. This implies that protein intake does not need to be exceptionally high to be used for body weight management’. |
| Krishnan S, 2014 | ( | Narrative review | USA | ‘We chose studies that fed high-fat diets and reported fat oxidation, EE, and weight maintenance’. | Not addressed | High-fat diets and weight maintenance | In conclusion, a high MUFA or PUFA diet appears to be more metabolically beneficial compared to a high SFA diet in terms of EE and weight maintenance. |
| Kim JE, 2016 | ( | SR and MA of RCTs ( | USA | ‘To assess and evaluate the effects of protein intake on dietary energy restriction–induced changes in body mass, lean mass, and fat mass in groups of adults with a mean age 50 years and older’. | Adults | Protein intake modified by protein supplementation and/or a prescribed higher protein diet; average energy deficit 500–750 kcal/d. The length of the energy restriction interventions ranged from 8 weeks to 2 years. | ‘Results from this systematic review and meta-analysis of findings from RCTs consistently indicate that older men and women better retain lean mass while losing body mass during periods of diet-induced energy restriction when they consume higher protein versus normal protein diets’. |
| F) Macronutrient composition – fats ( | |||||||
| Hooper L, 2015 | 220 ( | SR and MA of RCTs ( | UK | ‘To assess the effects of proportion of energy intake from fat on measures of weight and body fatness (including obesity, WC, and BMI in people not aiming to lose weight, using all appropriate randomized controlled trials (RCTs) and cohort studies in adults, children and young people’. | Children and adults | Proportion of energy intake from fat on body weight | ‘There is consistent evidence from RCTs in adults of a small weight-reducing effect of eating a smaller proportion of energy from fat; this was seen in almost all included studies and was highly resistant to sensitivity analyses. The effect of eating less fat (compared with usual diet) is a mean weight reduction of 1.5 kg (95% CI –2.0 to –1.1 kg), but greater weight loss results from greater fat reductions. The size of the effect on weight does not alter over time and is mirrored by reductions in body mass index (BMI) (–0.5 kg/m2, 95% CI –0.7 to –0.3) and waist circumference (–0.3 cm, 95% CI –0.6 to –0.02). Included cohort studies in children and adults most often do not suggest any relationship between total fat intake and later measures of weight, body fatness or change in body fatness. However, there was a suggestion that lower fat intake was associated with smaller increases in weight in middle-aged but not elderly adults, and in change in BMI in the highest validity child cohort’. |
| Hooper L, 2012 | ( | SR and MA of RCTs ( | UK | SR was needed of all available evidence of longer-term effects of total fat intake on body fatness, in studies not intending that participants lose weight. | Children and adults | Total fat intake and body fatness | ‘Diets lower in total fat on average reduced body weight by 1.6 kg, BMI by −0.51, and waist circumference by 0.3 cm. These effects were from randomised controlled trials in which weight loss was not an intended outcome, suggesting that they occur in people eating normal diets and the direction of effect on weight was consistent regardless of subgroups or sensitivity analyses’. |
| Martınez-Victoria E, 2012 | ( | SR of RCTs ( | Spain | ‘To determine the effect of n-3 PUFA supplementation or diets enriched in n-3 PUFA on body weight in adults, and…’ | Adults | n-3 PUFA and body weight | ‘The results of …. do not provide us with data robust enough as to conclude that n-3 PUFA can modify, and particularly reduce, body weight. Marked differences in experimental design, intervention type and duration, baseline characteristics of the participants (degree of obesity, associated condition, etc.), attrition rate, dose of n-3 PUFA and EPA/DHA ratio, make the results inconclusive and, in some cases, discordant’. |
| Mumme K, 2015 | ( | SR and MA of RCTs ( | New Zealand (?) | ‘To conduct a SR and meta-analysis of randomized controlled trials comparing the effects of MCTs, specifically C8:0 and C10:0, to long-chain triglycerides (LCTs) on weight loss and body composition in adults’. | Adults | MCTs, specifically C8:0 and C10:0, versus LCTs on weight loss 4–16 week | Consuming MCTs as part of a diet compared with LCTs may result in a small average reduction in body weight of 0.51 kg (range 0.80–0.23 kg) over an average 10-week period. |
| G) Water, tea, coffee, and alcohol ( | |||||||
| Muckelbauer R, 2014 | ( | SR of longitudinal ( | Germany | ‘To summarize the evidence from existing studies on the association between the consumption of water as a beverage and body weight outcomes’ | Children and adolescents | Water and body weight | ‘The longitudinal association seemed to be inverse, indicating that increased water consumption might reduce the risk for excessive weight gain in childhood. However, evidence was very limited because this trend was shown by only three longitudinal studies, while one longitudinal study did not find this association. Overall, the evidence for any causal association between water consumption and body weight outcomes is very low due to the sparse existing literature on this association and due to the type of existing studies being mainly cross-sectional’ |
| Muckelbauer R, 2013 | ( | SR of RCTs ( | Germany | ‘To systematically summarize all existing evidence of the association between dietary water consumption and weight-related outcomes in adults’. | Adults | Water and body weight | ‘Of the studies with populations participating in a program for weight loss or maintenance, 2 studies – 1 nonrandomized interventional trial and 1 observational longitudinal study – showed that increased water consumption has the potential to reduce body weight’. |
| Yang CS, 2016 | ( | Narrative review | USA/China | ‘This article reviews the evidence and discusses the molecular mechanisms for the mitigation of overweight and MetS, as well as related prevention of diabetes and CVDs by different types of tea’. | Not defined | Tea and body weight referred | ‘Tea consumption at the levels of three to four cups (600–900 mg tea catechins) or more a day has shown to reduce body weight gain, alleviate MetS, and reduce the risk for diabetes and CVDs’. |
| Hursel R, 2013 | ( | Narrative review | The Netherlands | ‘Results from different types of studies, such as intervention studies and observational studies, are discussed to give a detailed overview of the evidence on tea as weight-controlling ingredient’. | Adults | Tea and body weight | ‘Studies and meta-analyses of catechin- and caffeine-rich teas (CCRTs) in most cases showed improved anthropometric variables such as BW, BMI, body fat mass, and waist:hip ratio’. |
| Sayon-Orea C, 2011 | ( | SR of 14 cross-sectional studies, 13 prospective cohort studies, and four intervention trials | Spain | ‘To systematically review the effects of alcohol consumption on body weight’. | Adults | Alcohol and body weight | ‘Most of the cross-sectional studies found a positive association between alcohol consumption and body weight or measures of abdominal adiposity (WC or WHR), especially in heavy drinkers and binge drinkers, whereas moderate consumption was either negatively associated or not associated with body weight or abdominal adiposity’. |
| H) Meat | |||||||
| An R, 2020 | ( | SR of RCTs ( | USA | ‘Aimed at systematic identification and synthesis of the scientific evidence on pork consumption in relation to body weight’ | Adults aged 18 years and older | Pork consumption/body weight and composition | ‘Meta-analysis found that among the experimental studies without energy restrictions, pork intake was associated with a reduction in body weight by 0.86 kg and body fat percentage by 0.77%; among the experimental studies with energy restrictions, pork intake was associated with a reduction in body weight by 5.56 kg, lean mass by 1.50 kg, and fat mass by 6.60 kg; and among the observational studies, pork intake was not associated with overweight or obesity status’. |